Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?
Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?
复制标题
DOI:
10.1200/jco.1998.16.10.3216
复制
发表时间:
1998-10-01
影响因子:
45.3
通讯作者:
De Conno, F
中科院分区:
文献类型:
--
作者:
Ripamonti, C;Groff, L;De Conno, F
Purpose: To define the dose ratio between morphine and methadone in relation to the previous morphine dose and the number of days needed to achieve the same level of analgesia in a group of patients with advanced cancer with pain who switched from morphine to oral methadone.Patients and Methods: A cross-sectional prospective study of 38 consecutive cancer patients who switched from morphine to oral methadone was performed. The intensity of pain before, during, and after the switching period was assessed through a four-point verbal Likert scale. The relationship between previous morphine dose and the final equianalgesic methadone dose, dose ratio between morphine and methadone, and the number of days required to achieve equianalgesia have been examined by means of pearson's correlation coefficient, scatter plots, and Cuzick's test for trend respectively.Results: Before the switch, the median oral equivalent daily dose of morphine was 145 mg/d; after the switch, the median equianalgesic oral methadone dose wets 21 mg/d. A median time of 3 days (range, 1 to 7 days) was necessary to achieve the equianalgesia with oral methadone; the lower the preswitching morphine dose, the fewer days necessary to achieve equianalgesia with oral methadone (P